Treatment of co-insulin infections
I. EVALUATION
After insulin co-infection, a comprehensive assessment of the overall situation of the patient begins. This includes the monitoring of vital signs (temperature, blood pressure, heart rate, breathing, etc.) to see if the patient is suffering from all-body infections such as heat, cold warfare, acute breathing and early signs of shock. The extent and extent of abdominal abdominal pain and abdominal abdominal abdominal abdominal abdominal abdominal abdominal abdominal abdominal pain and absiliation are determined in a preliminary manner. At the same time, the relevant laboratory tests have been improved, such as blood routines (with a focus on white cell count, meso-particle cell ratio and absolute values indicators of inflammation), blood biochemicalization (understanding of liver and kidney function, electrolyte level, assessment of patient ‘ s nutritional and internal state), C-reacting indicators of infection such as protein (CRP), calcium calcium (PCT), and insusterase levels (drydase, fat enzymes, etc.) to assist in the assessment of progress. In addition, video screenings, such as abdominal ultrasound, CT etc., are required to determine the area, extent of insulin and the presence of abdominal sepsis, sepsis, etc., to provide the basis for the development of a follow-up treatment programme.
II. Non-surgery
1. Full diversion
This is a critical first step to reduce the pressure and the continuous irritation of the infection in the abdominal cavity by drawing out pancreas, septus, etc. from the cavity by guiding the flow of the pedal penetrator under the guidance of ultrasound or CT. The selection of the lead tube should be considered in the light of such factors as the location, volume and viscosity of the fluid, so as to ensure a smooth flow and prevent congestion or displacement of the lead tube. Quantities, colours, sexual characteristics of fluids are regularly observed and sent for laboratory examinations, including starch enzymes, bacterial culture and drug-sensitive tests, in order to adapt the treatment programme to the results in a timely manner.
2. Treatment against infection
On the basis of experience, broad-species, high-efficiency antibiotics are selected to cover the gerang fungus (e.g. coli and crabella, which are common intestine infections) and gerang positives (e.g. intestinal fungi), taking into account anaerobic cover. Upon the return of bacterial development and drug-sensitive results, they are adjusted in a timely manner to sensitive antibiotics to ensure the relevance and effectiveness of anti-infection treatment. In the course of treatment, changes in infection indicators, such as the patient ‘ s temperature, blood protocol, CRP, PCT, etc., are closely observed, and the effectiveness of anti-infection treatment is assessed. The course of treatment of generic antibiotics, usually 2 – 4 weeks or more, depending on the severity of the condition, until the infection is fully controlled, and the indicators return to normal.
3. Nutritional support
Nutritional support is essential in view of the high level of decomposition metabolic and possible effects on gastrointestinal functions. Priority is given to intestine nutrition, which can be combined if the intestinal function of the patient is not fully restored or resistant to intestine nutrition. Intestine nutrient formulations should select formulations that are protein-rich, high-heat, easily digestible, and with low excretion stimulation of pancreas, be given progressively more nutritional doses and concentrations to meet the nutritional needs of patients, promote acoustic healing and body recovery, while helping to maintain intestinal mucous barrier functions and reduce the increased risk of infection from intestinal bacterial transfer.
4. Injection of pancreas
The use of growth inhibitors and their analogues (e.g., octopus) helps to heal insulin by inhibiting the excretion function of pancreas, reducing the amount of incubation, and reducing the flow of insulin leakage. The delivery method of continuous intravenous injection is generally used, with specific doses and treatments adjusted to the patient ‘ s condition and pancreas, while the adverse effects of drugs, such as gastrointestinal reaction, blood sugar abnormalities, etc. are closely observed.
5. Maintenance of water, electrolyte and acid alkali balance
Water, electrolyte and acid-alkali imbalances are likely to occur due to the potential for significant ingestion, heat and ingestion. Periodic monitoring of indicators such as serolytete (potassium, sodium, chlorine, calcium, etc.) and blood-gas analysis of patients, based on the results of timely resupply of liquids and electrolytes, correction of the acid-alkali imbalance and maintenance of internal environmental stability are important for the overall recovery of patients and normal maintenance of the function of organs.
III. Surgery
If, after a period of active non-surgery treatment (usually 2 – 4 weeks), the incidence of insulin co-infection is not effectively controlled, such as the persistence of abscesses in the abdominal cavity, a lack of flow, serious haemorrhage complications or a combination of other serious pathologies (e.g. gastrointestinal fistula), surgical treatment is considered. The procedures include:
1. Euphemism and seduction
The abdominal abdominal tissue, sepsis and insulin seepages are completely removed during the operation, and the puss are fully induced, which can be done in a manner that ensures a smooth flow after the operation and reduces the risk of re-infection, using multiple lead tubes or double tubes. At the same time, the specific areas of pancreas should be identified as far as possible and, if necessary, simple repair or treatment of the fistula should be undertaken, while care should be taken to avoid over-operations leading to an increase in or difficulty in healing the fistula.
2. Pancreatic partial excision (applies to specific circumstances)
In cases of severe pancreas break-ups, large insulin leaks and difficult to heal after conservative treatment, or in cases of severe local pancreas deaths and uncontrolled infections, some of the pancreas tissues may be considered for removal, but this procedure is more traumatic and has a relatively high incidence of post-operative complications, requiring strict control of the surgical adaptation certificate and adequate pre-operative assessment and preparation of the patient ‘ s whole body condition and risk.
Treatment of co-insulin infections requires a comprehensive consideration of the specific situation of the patient, following the principle of individualization and gradual progress, closely observing changes in the situation, and adapting treatment programmes in a timely manner in order to improve the effectiveness of treatment, reduce the incidence of mortality and complications among patients and promote their rehabilitation.
